[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Pages 14371-14372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04701]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0015; NIOSH 278]


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention announces the following meeting of the 
Board of Scientific Counselors, National Institute for Occupational 
Safety and Health (BSC, NIOSH). This is a virtual meeting. It is open 
to the public, limited only by the number of web conference lines (500 
web conference lines are available). Time will be available for public 
comment.

DATES: The meeting will be held on April 21, 2023, from 10 a.m. to 3 
p.m., EDT.
    Written comments must be received on or before April 14, 2023.

ADDRESSES: If you wish to attend the meeting, please register at the 
NIOSH website at https://www.cdc.gov/niosh/bsc/ or by telephone at 
(202) 245-0649 no later than April 14, 2023.
    You may submit comments, identified by Docket No. CDC-2023-0015; 
NIOSH-278 by either of the methods listed below. CDC does not accept 
comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Ms. Sherri Diana, NIOSH Docket Office, National 
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, 
Mailstop C-34, Cincinnati, Ohio 45226. Attn: Docket No. CDC-2023-0015; 
NIOSH-278.
    Instructions: All submissions received must include the Agency name 
and docket number. Docket number CDC-2023-0015; NIOSH-278 will close 
April 14, 2023.

FOR FURTHER INFORMATION CONTACT: Maria Strickland, M.P.H., Designated 
Federal Officer, BSC, NIOSH, CDC, Patriots Plaza 1, 395 E Street SW, 
Suite 9200, Washington, DC 20201; Telephone: (202) 245-0649; Email: 
MStric[email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Secretary of Health and Human Services, the 
Assistant Secretary for Health, and by delegation the Director, Centers 
for Disease Control and Prevention, are authorized under Sections 301 
and 308 of the Public Health Service Act to conduct directly, or by 
grants or contracts, research, experiments, and demonstrations relating 
to occupational safety and health and to mine health.
    Purpose: The Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH) provides advice to the 
Director, National Institute for Occupational Safety and Health, on 
NIOSH research and prevention programs. The Board also provides 
guidance on the Institute's research activities related to developing 
and evaluating hypotheses, systematically documenting findings, and 
disseminating results. In addition, the Board evaluates the degree to 
which the activities of NIOSH: (1) conform to those standards of 
scientific excellence appropriate for federal scientific institutions 
in accomplishing objectives in occupational safety and health; (2) 
address currently relevant needs in the fields of occupational safety 
and health either alone or in conjunction with other known activities 
inside and outside of NIOSH; and (3) produce their intended results in 
addressing important research questions in occupational safety and 
health, both in terms of applicability of the research findings and 
dissemination of the findings.
    Matters to be Considered: The agenda for the meeting addresses Per- 
and Polyfluoroalkyl Substances and Occupational Safety and Health 
Economics. Agenda items are subject to change as priorities dictate.
    The agenda is also posted on the NIOSH website at https://www.cdc.gov/niosh/bsc/.

Public Participation

    Written Public Comment: Written comments will be accepted per the 
instructions provided in the addresses section above. Comments received 
in advance of the meeting are part of the public record and are subject 
to public disclosure. Written comments will be included in the official 
record of the meeting. Do not include any information in your comment 
or supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other information that identifies you in the body of your comments, 
that information will be on public display. CDC will review all 
submissions and may choose to redact, or withhold, submissions 
containing private or proprietary information such as Social Security 
numbers, medical information, inappropriate language, or duplicate/
near-duplicate examples of a mass-mail campaign. CDC will carefully 
consider all comments submitted into the docket.
    Written comments received by April 14, 2023, will be provided to 
the Board prior to the meeting.
    Oral Public Comment: The public is welcome to participate during 
the public comment period, from 1:30 p.m. to 1:45 p.m., EDT, April 21, 
2023. Each commenter will be provided up to five minutes for comment. A 
limited number of time slots are available and will be assigned on a 
first-come, first-served basis. Members of the public who wish to 
address the BSC, NIOSH are requested to contact the Designated Federal 
Officer for scheduling purposes (see FOR FUTHER INFORMATION CONTACT 
above).
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 14372]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04701 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P